The FDA has warned that ketamine and compounded ketamine products aren’t approved to take care of any psychiatric disorder. This means that they haven’t been tested being Protected or successful. In 2019, the FDA approved a nasal spray called esketamine (Spravato) that’s derived from ketamine for treatment-resistant depression, but only in su